Christine Ring is CLO at Nurix Therapeutics, Inc. (NRIX). They have made 20 open-market trades across 1 company since 2021, most recently 2026-10-02.
CIK 0001817199
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NRIX | 9,110 | $222K |
Shares reported on the most recent Form 4, priced at the 2026-10-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NRIX | SELL · 10b5-1 | 2026-10-02 | 2026-10-02 | $23.19 | $134K | +3.4% | — | — |
| NRIX | SELL · 10b5-1 | 2026-09-02 | 2026-09-02 | $25.76 | $149K | -3.7% | -10.8% | — |
| NRIX | SELL · 10b5-1 | 2026-08-03 | 2026-08-03 | $23.05 | $382K | +14.7% | +8.7% | — |
| NRIX | SELL | 2026-07-30 | 2026-07-30 | $23.38 | $90K | +10.5% | +9.7% | — |
| NRIX | SELL · 10b5-1 | 2026-07-02 | 2026-07-02 | $23.56 | $259K | +0.0% | -2.6% | -0.8% |
| NRIX | SELL · 10b5-1 | 2026-06-25 | 2026-06-25 | $20.06 | $581K | +6.5% | +2.5% | +4.6% |
| NRIX | SELL · 10b5-1 | 2026-06-02 | 2026-06-02 | $16.60 | $135K | +4.9% | +48.3% | +59.2% |
| NRIX | SELL · 10b5-1 | 2026-05-04 | 2026-05-04 | $16.96 | $138K | -7.4% | -10.6% | +34.5% |
| NRIX | SELL · 10b5-1 | 2026-05-01 | 2026-05-01 | $16.76 | $90K | -2.6% | +4.6% | +41.8% |
| NRIX | SELL | 2026-04-30 | 2026-04-30 | $16.65 | $53K | -3.8% | +4.8% | +42.2% |
| NRIX | SELL · 10b5-1 | 2026-04-02 | 2026-04-02 | $15.24 | $124K | +7.6% | +7.4% | +51.6% |
| NRIX | SELL · 10b5-1 | 2026-03-02 | 2026-03-02 | $15.44 | $126K | +1.8% | +1.0% | +13.4% |
| NRIX | SELL · 10b5-1 | 2026-02-09 | 2026-02-09 | $16.66 | $238K | -6.7% | -5.7% | -3.7% |
| NRIX | SELL | 2026-01-30 | 2026-01-30 | $16.60 | $73K | -2.5% | -4.3% | +1.1% |
| NRIX | SELL | 2026-01-20 | 2026-01-20 | $18.42 | $69K | -9.1% | -13.1% | -6.2% |
| NRIX | SELL · 10b5-1 | 2025-12-18 | 2025-12-18 | $17.89 | $131K | +5.4% | +1.3% | -16.4% |
| NRIX | SELL · 10b5-1 | 2025-11-24 | 2025-11-24 | $17.07 | $642K | +5.7% | +13.1% | -10.2% |
| NRIX | SELL | 2025-10-30 | 2025-10-30 | $12.80 | $47K | +2.0% | +34.1% | +41.7% |
| NRIX | SELL | 2025-07-30 | 2025-07-30 | $12.01 | $46K | -16.5% | -19.1% | +3.0% |
| NRIX | SELL | 2025-04-30 | 2025-04-30 | $11.50 | $33K | -10.8% | -6.8% | +4.2% |
| NRIX | SELL · 10b5-1 | 2025-01-31 | 2025-02-03 | $19.94 | $228K | -7.1% | -24.6% | -42.2% |
| NRIX | SELL | 2025-01-30 | 2025-01-30 | $19.83 | $122K | -14.6% | -29.2% | -42.5% |
| NRIX | SELL · 10b5-1 | 2025-01-02 | 2025-01-02 | $19.50 | $112K | +3.3% | -2.9% | -41.7% |
| NRIX | SELL · 10b5-1 | 2024-12-02 | 2024-12-02 | $21.73 | $250K | -2.3% | -7.3% | -32.6% |
| NRIX | SELL · 10b5-1 | 2024-11-04 | 2024-11-04 | $25.00 | $82K | +6.8% | -17.2% | -24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.